effects [qlco]
Transdermal [ftcn]
Oral [spco]
Estrogen [horm, phsu, strd]
Supplementation [topp]
Endothelial [tisu]
function [phsf]
Inflammation [patf]
Cellular [cell]
redox state [moft]
Incidence [qnco]
ischaemic heart disease [dsyn]
Show [inpr]
Sharp [fndg]
Menopause [phsf]
effects [qlco]
Hormone replacement therapy [topp]
Cardiovascular disease [dsyn]
controversies [socb]
Not [ftcn]
Only [qnco]
Oxidative Stress [comd]
Inflammation [patf]
Suggest [idcn]
To [qlco]
Play [dora]
Role [socb]
pathogenesis [ftcn]
cardiovascular events [fndg]
Compared [acty]
effects [qlco]
Hormone replacement therapy [topp]
Endothelial [tisu]
function [phsf]
Cellular [cell]
Antioxidant [phsu]
System [ftcn]
Inflammation [patf]
Oral [spco]
Transdermal Administration [ftcn]
Mild [qlco]
postmenopausal [tmco]
Women [popg]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Replacement [topp]
Patients [podg]
Mean [qnco]
Age-Years [tmco]
weeks [tmco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Patients [podg]
Mean [qnco]
Age-Years [tmco]
weeks [tmco]
Flow [npop]
mediated [socb]
Endothelium [tisu]
Dependent [qlco]
Dilation [patf]
Brachial Artery [bpoc]
Serum [bdsu]
Level [qlco]
Thioredoxin [aapp, bacs]
Marker [clna]
Antioxidant [phsu]
System [ftcn]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Measured [qlco]
Flow [npop]
mediated [socb]
Vasodilation [phsf]
Increased [qnco]
Hormone replacement therapy [topp]
Oral [spco]
baseline [bodm]
Transdermal [ftcn]
P NOS [aapp, imft]
baseline [bodm]
Thioredoxin [aapp, bacs]
Levels [qlco]
Decreased [qnco]
Hormone replacement therapy [topp]
Oral [spco]
Transdermal [ftcn]
ng/mL [qnco]
P NOS [aapp, imft]
baseline [bodm]
Variation [qlco]
Flow [npop]
mediated [socb]
Vasodilation [phsf]
Thioredoxin [aapp, bacs]
Concentrations [menp]
Group [idcn]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
Increased [qnco]
Oral [spco]
Hormone replacement therapy [topp]
mg dl [qnco]
P NOS [aapp, imft]
baseline [bodm]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Not [ftcn]
elicit [qlco]
mg dl [qnco]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Concentrations [menp]
Group [idcn]
Analyzed [resa]
P NOS [aapp, imft]
Oral [spco]
Hormone replacement therapy [topp]
Inflammation [patf]
Transdermal [ftcn]
Not [ftcn]
Oral [spco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Improved [qlco]
Endothelial [tisu]
function [phsf]
Decreased stress [fndg]
Oxidative [ftcn]
Affecting [ftcn]
Cellular [cell]
redox state [moft]
Differential [qlco]
effects [qlco]
Course [tmco]
Administration [ocac]
Affect [menp]
Future [tmco]
cardiovascular events [fndg]
Transdermal [ftcn]
Not [ftcn]
Oral [spco]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Improved [qlco]
Endothelial [tisu]
function [phsf]
Decreased stress [fndg]
Oxidative [ftcn]
Affecting [ftcn]
Cellular [cell]
redox state [moft]
Differential [qlco]
effects [qlco]
Course [tmco]
Administration [ocac]
Affect [menp]
Future [tmco]
cardiovascular events [fndg]
